SCHEMBL29425816

SCHEMBL29425816

O=C(OC1C=C(CO)C2C(OC3OC(CO)C(O)C(O)C3O)OC=CC12)c1ccc(O)cc1

nearest known ligand 0.63

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.63
▸ HSP90AA1 P07900 9/20 0.60
▸ ELANE P08246 1/20 0.45
▸ XDH P47989 1/20 0.43
▸ TYR P14679 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30561993 0.85 HSP90AA1 (0.62) L3MBTL1HSP90AA1ELANEXDHPOLB
SCHEMBL421128 0.85 L3MBTL1 (0.70) L3MBTL1HSP90AA1ELANEPOLBCTDSP1
Agnuside SCHEMBL382107 0.83 L3MBTL1 (0.67) L3MBTL1HSP90AA1XDHTYR
Agnuside SCHEMBL13208121 0.83 L3MBTL1 (0.67) L3MBTL1HSP90AA1XDHTYR
Agnuside SCHEMBL24174405 0.83 L3MBTL1 (0.67) L3MBTL1HSP90AA1XDHTYR
Aucubin SCHEMBL381032 0.78 L3MBTL1 (1.00) L3MBTL1HSP90AA1ELANEXDH
Aucubin SCHEMBL22680275 0.78 L3MBTL1 (1.00) L3MBTL1HSP90AA1ELANEXDH
Aucubin SCHEMBL22680274 0.78 L3MBTL1 (1.00) L3MBTL1HSP90AA1ELANEXDH
SCHEMBL29425914 0.78 HSP90AA1 (0.63) L3MBTL1HSP90AA1ELANEXDH
SCHEMBL7153129 0.76 L3MBTL1 (0.67) L3MBTL1HSP90AA1XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4702037-A1 METHOD OF PRODUCING IRIDOIDS Nicoventures Trading Limited (GB) 2026-03-04 — — EP disclosed
WO-2024224085-A1 METHOD OF PRODUCING IRIDOIDS Nicoventures Trading Limited (GB) 2024-10-31 — — WO disclosed
EP-3409766-B1 AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS N ZYME BIOTEC GMBH (DE) 2022-03-09 — — EP disclosed
Send feedback